Overview


According to FutureWise analysis the market for equine veterinary therapeutics in 2023 is US$ 1.3 billion, and is expected to reach US$ 2.24 billion by 2031 at a CAGR of 7.02%.

Equine veterinary therapeutics refers to the field of equine healthcare that deals with the prevention and treatment of various diseases. Equine veterinary therapeutics include drugs and vaccines that are used for the treatment and prevention of equine diseases, additives that are used for the overall maintenance of health and the provision of adequate minerals for a healthy life. The overall veterinary therapeutic market has grown in recent years as people become more aware of veterinary healthcare.

Equine veterinary therapeutics market growth is and has been attributed to the increasing importance of horses in human life. Equine veterinary therapeutic market is expected to grow due to the increasing zoonotic diseases affecting horses. Increasing awareness concerning the prevention and well-being of livestock and companion animals is expected to drive the market for equine veterinary therapeutics.

Equine veterinary therapeutics is the branch of equine healthcare that deals with the prevention and treatment of various diseases. In equine veterinary therapeutics, we refer to drugs that are used for the treatment of equine diseases, vaccines that are used for the prevention of several diseases, and additives that are used for maintaining the overall health of the animal and for providing sufficient minerals. Equine veterinary therapeutics are expected to gain traction due to the rising number of zoonotic diseases affecting horses. Equine veterinary therapeutics market is expected to grow due to the increasing awareness about livestock and companion animals. Equestrian activities include horse racing and betting, leisure and competitive riding. Horses are also used in equine-facilitated therapy, which addresses specific motor, sensory, and social issues.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Equine Veterinary Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Equine Veterinary Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  Merck Animal Heath
  •  Affymetrix
  •  Elanco Animal Heath
  •  Zoetis (Pfizer Animal Health)
  •  Equine Health U.K.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  •  Drugs
    •  Anti- Inflammatory
    •  Anti – Infective
    •  Parasiticides
  •  Vaccines
    •  Recombinant vaccines
    •  Inactivated Vaccines
    •  Live attenuated vaccines
    •  Feed additives
  •  Vitamins
    •  Antibiotics
    •  Amino acids
    •  Enzymes
    •  Others

By Route of Administration

  •  Oral
  •  Parental
  •  Topical

By Distribution Channel

  •  Veterinary Hospital
  •  Veterinary Clinics
  •  Pharmacies and drug stores
  •  E-commerce
  •  Other

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa
  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants
  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth
  •  To provide with an exhaustive analysis on the Equine Veterinary Therapeutics Market By Product Type, By Route of Administration, By Distribution Channel and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Equine Veterinary Therapeutics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Equine Veterinary Therapeutics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Equine Veterinary Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Equine Veterinary Therapeutics Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drugs
         1.1. Anti- Inflammatory
         1.2. Anti – Infective
         1.3. Parasiticides
        2. Vaccines
         2.1. Recombinant vaccines
         2.2. Inactivated Vaccines
         2.3. Live attenuated vaccines
         2.4. Feed additives
        3. Vitamins
         3.1. Antibiotics
         3.2. Amino acids
         3.3. Enzymes
         3.4. Others

  • 8.   Equine Veterinary Therapeutics Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Parental
        3. Topical

  • 9.   Equine Veterinary Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary Hospital
        2. Veterinary Clinics
        3. Pharmacies and drug stores
        4. E-commerce
        5. Other

  • 10.   North America Equine Veterinary Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Equine Veterinary Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Equine Veterinary Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Equine Veterinary Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Merck Animal Heath
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Affymetrix
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Elanco Animal Heath
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Zoetis (Pfizer Animal Health)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Equine Health U.K.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients